Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan

Title
Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan
Authors
Keywords
Clinical parameters, FOLFIRINOX, Laboratory parameters, Prognosis, Risk categories
Journal
Clinical Colorectal Cancer
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2019-09-05
DOI
10.1016/j.clcc.2019.08.004

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started